Clinical observations highlight hypertensive uveitis risks after faricimab treatment, suggesting important considerations for clinicians.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Guanghao Qin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: